With Biotech stocks running into a speed-bump in the past couple sessions including today, we have seen some liquidations in the levered long LABU (Direxion Daily S&P Biotech Bull 3X, Expense Ratio 1.09%).
NYSE:LABU September 6, 2017 12:20pm
Triple Leveraged Biotech Fund Sees Massive Outflows As Biotech Cools (LABU)
Direxion Investments Launches Four Leveraged ETFs For Active Traders
Direxion Investments announces the launch of four new daily leveraged exchange-traded funds (ETFs).
FUND LAUNCH May 28, 2015 3:19pm